Dermapharm Holding SE (ETR:DMP)
39.35
+0.55 (1.42%)
Feb 21, 2025, 5:35 PM CET
Dermapharm Holding SE Revenue
Dermapharm Holding SE had revenue of 314.56M EUR in the quarter ending September 30, 2024, with 9.48% growth. This brings the company's revenue in the last twelve months to 1.17B, up 0.17% year-over-year. In the year 2023, Dermapharm Holding SE had annual revenue of 1.15B with 10.59% growth.
Revenue (ttm)
1.17B
Revenue Growth
+0.17%
P/S Ratio
1.81
Revenue / Employee
335.70K
Employees
3,497
Market Cap
2.12B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.15B | 110.19M | 10.59% |
Dec 31, 2022 | 1.04B | 80.46M | 8.38% |
Dec 31, 2021 | 960.09M | 151.78M | 18.78% |
Dec 31, 2020 | 808.31M | 93.94M | 13.15% |
Dec 31, 2019 | 714.38M | 130.28M | 22.30% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 22.67B |
Merck KGaA | 20.96B |
Bayer Aktiengesellschaft | 46.74B |
Fresenius SE & Co. KGaA | 22.81B |
Sartorius Aktiengesellschaft | 3.38B |
Fresenius Medical Care AG | 19.24B |
Carl Zeiss Meditec AG | 2.08B |
SCHOTT Pharma AG & Co. KGaA | 954.68M |
Dermapharm Holding SE News
- 7 weeks ago - EQS-DD: Dermapharm Holding SE: Wilhelm Beier, buy - Wallstreet:Online
- 3 months ago - EQS-DD: Dermapharm Holding SE: Dr. Hans-Georg Feldmeier, buy - Wallstreet:Online
- 3 months ago - EQS-DD: Dermapharm Holding SE: Christof Dreibholz, buy - Wallstreet:Online
- 6 months ago - Dermapharm Holding SE: High-Margin Pharma Boosts Global Organic Growth - Wallstreet:Online
- 6 months ago - EQS-News: Dermapharm Holding SE: High-margin existing business in branded pharmaceuticals segment drives organic growth at German and international companies - Wallstreet:Online
- 6 months ago - Dermapharm Holding: Thriving on High-Margin Organic Growth in Pharma Business - Wallstreet:Online
- 6 months ago - EQS-News: Sustained organic growth in high-margin existing branded pharmaceutical business - Wallstreet:Online